News Highlights: Top Company News of the Day
27 May 2019 - 1:30PM
Dow Jones News
Renault, Fiat Chrysler Discuss Merger as Part of Alliance Talks
Renault and Fiat Chrysler are discussing the possibility of a
merger, according to people familiar with the matter, as the auto
makers explore options for combining their businesses to better
cope with slowing sales and the expensive challenge of electric
vehicles and self-driving cars.
Teva Settles Oklahoma Opioid Case for $85 Million
The Israel-based drugmaker agreed to pay $85 million to resolve
claims by the state of Oklahoma that the company's marketing helped
fuel a rise in opioid addiction.
In Newly Released Deposition, OxyContin Owner Defends Response to Reports of Abuse
A deposition of Richard Sackler, an owner of OxyContin maker
Purdue Pharma, from March offers a rare window into his current
views on the opioid epidemic amid litigation seeking to hold the
company accountable for the crisis.
Refiners Poised for Boost From Clean-Fuel Rules
U.S. refiners are anticipating a bonanza from new rules that
require cleaner-burning fuels on the world's oceangoing ships
starting Jan. 1.
MIT Scientist's Biotech Research Is Called Into Question
MIT researcher Dr. Ram Sasisekharan and his team are defending
their computer-assisted research against an accusation that they
misled the scientific community about the discovery of drugs for
the flu and Zika viruses.
Judge Bars Bud Light From Suggesting Rival Beers Contain Corn Syrup
A judge temporarily barred Bud Light from suggesting in its
advertising that rival beers Coors Light and Miller Lite contain
corn syrup.
MAX's Return to Flight Delayed by FAA's Re-Evaluation of Safety Procedures for Older 737 Models
A review of Boeing's 737 MAX jets has expanded to include
emergency procedures used by pilots on earlier 737 models, further
delaying the MAX's return to service.
Facebook Privacy Settlement Delayed by FTC Split
A long-awaited multibillion-dollar settlement between Facebook
and federal regulators over privacy missteps has been bogged down
by a split between Republicans and Democrats on the Federal Trade
Commission.
At $2 Million, New Novartis Drug Is Priciest Ever
Novartis said it plans to price its recently approved gene
therapy at $2.125 million, making it the world's most expensive
medicine.
Loeb's Hedge Fund Wants Centene to Consider Selling Itself
Daniel Loeb's Third Point has built a stake in Centene and wants
the health insurer to consider selling itself before spending $15.3
billion to purchase WellCare Health Plans.
(END) Dow Jones Newswires
May 26, 2019 23:15 ET (03:15 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.